Analyst Ranking
Bottom 13%
#4299 out of 4929 analysts
Average Return
-0.85%
Win Rate
31%35 out of 113
Risk vs Reward
Poor
Good

Elemer Piros's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Monopar TherapeuticsMNPR
+559.09%$5.50$36.25
2024-10-10 -
2025-07-03
Strong Buy
Arrowhead Pharmaceuticals IncARWR
+371.70%$13.96$65.85
2018-12-16 -
2019-12-17
Strong Buy
Mind Medicine IncMNMD
+222.26%$3.01$9.70
2023-03-09 -
2024-03-08
Strong Buy
Mind Medicine IncMNMD
+206.01%$3.16$9.67
2023-04-13 -
2024-04-12
Strong Buy
Mind Medicine IncMNMD
+193.26%$3.41$10.00
2023-05-04 -
2024-05-03
Strong Buy

Elemer Piros Analyst Color

Get additional color on Elemer Piros's coverage of popular stocks

Elemer Piros's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bioxcel Therapeutics IncBTAI
1Strong Buy$65.00+3,267.88%Initiates Coverage On
4 months ago
Fibrobiologics IncFBLG
1Strong Buy$12.00+1,860.78%Initiates Coverage On
7 months ago
Tharimmune IncTHAR
1Strong Buy$17.00+813.98%Initiates Coverage On
7 months ago
Quince Therapeutics IncQNCX
1Strong Buy$11.00+583.23%Initiates Coverage On
8 months ago
Monopar TherapeuticsMNPR
6Strong Buy$50.00+37.93%Initiates Coverage On
9 months ago
Mira Pharmaceuticals IncMIRA
1Strong Buy$17.00+1,316.67%Initiates Coverage On
9 months ago
Athira Pharma IncATHA
1Strong Buy$22.00+6,370.59%Initiates Coverage On
a year ago
Cassava Sciences IncSAVA
1Strong Buy$107.00+5,223.38%Reiterates
a year ago
Cognition Therapeutics IncCGTX
1Strong Buy$14.00N/AReiterates
a year ago
Annovis Bio IncANVS
1Strong Buy$67.00N/AReiterates
a year ago
Alto Neuroscience IncANRO
1Strong Buy$43.00N/AInitiates Coverage On
a year ago
Coya Therapeutics IncCOYA
7Strong Buy$18.00N/AInitiates Coverage On
a year ago
Hoth Therapeutics IncHOTH
3Strong Buy$7.50N/AMaintains
2 years ago
Atai Life Sciences NvATAI
8Strong Buy$15.00N/AReiterates
2 years ago
Mind Medicine IncMNMD
8Strong Buy$21.00N/AReiterates
2 years ago
Compass Pathways PLCCMPS
9Strong Buy$38.00N/AReiterates
2 years ago
Pasithea Therapeutics CorpKTTA
2Strong Buy$40.00N/AReiterates
2 years ago
Unicycive Therapeutics IncUNCY
5Strong Buy$50.00N/AReiterates
2 years ago
Cybin IncCYBN
3Strong Buy$114.00N/AReiterates
2 years ago
Clene IncCLNN
6Strong Buy$200.00N/AMaintains
2 years ago
Opthea LtdOPT
2Strong Buy$23.00N/AReiterates
2 years ago
Gh Research PLCGHRS
3Strong Buy$33.00N/AReiterates
2 years ago
Reunion Neuroscience IncREUN
2Strong Buy$11.00N/AReiterates
2 years ago
Apellis Pharmaceuticals IncAPLS
6Strong Sell$40.00N/ADowngrades
3 years ago
Unity Biotechnology IncUBX
3Strong Buy$40.00N/AUpgrades
4 years ago
Biorestorative Therapies IncBRTX
1Strong Buy$37.00N/AInitiates Coverage On
4 years ago
Diamedica Therapeutics IncDMAC
2Strong Buy$32.00N/AMaintains
4 years ago
Global Blood Therapeutics IncGBT
5Strong Buy$124.00N/AMaintains
4 years ago
Durect CorpDRRX
1Strong Buy$70.00N/AInitiates Coverage On
5 years ago
Cohbar IncCWBR
1Strong Buy$240.00N/AInitiates Coverage On
5 years ago
Arcturus Therapeutics Holdings IncARCT
1Strong Buy$77.00N/AReinstates
5 years ago
Polarityte IncPTEIQ
2Strong Buy$75.00N/AMaintains
5 years ago
Intercept Pharmaceuticals IncICPT
3Strong Buy$191.00N/AReiterates
6 years ago
Spark Therapeutics IncONCE
2Hold$114.50N/ADowngrades
6 years ago
Arrowhead Pharmaceuticals IncARWR
3Strong Buy$165.00N/AMaintains
7 years ago
Zynerba Pharmaceuticals IncZYNE
2Strong Buy$21.00N/AInitiates Coverage On
7 years ago
Corbus Pharmaceuticals Holdings IncCRBP
4Strong Buy$1,080.00N/AMaintains
7 years ago
Krystal Biotech IncKRYS
1Strong Buy$28.00N/AInitiates Coverage On
7 years ago
Strongbridge Biopharma PLCSBBP
2Strong Buy$17.00N/AMaintains
7 years ago
Corner Growth Acquisition CorpCOOL
1Strong Buy$65.00N/AMaintains
7 years ago
Dynavax Technologies CorpDVAX
2Strong Buy$250.00N/AMaintains
8 years ago
Aldeyra Therapeutics IncALDX
1Strong Buy$22.00N/AInitiates Coverage On
8 years ago
Abeona Therapeutics IncABEO
1Strong Buy$850.00N/AMaintains
8 years ago
Ocular Therapeutix IncOCUL
1Strong Buy$21.00N/AMaintains
8 years ago
Omeros CorpOMER
1Hold$15.00N/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.